C143H110F15N49O7 — CID 159651534
2-[2,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-(4-pyridin-3-ylpyrazol-1-yl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]pyrazol-1-yl]acetamide (PubChem CID 159651534) has the molecular formula C143H110F15N49O7 and a molecular weight of 2911.76 g/mol. Its IUPAC name is 2-[2,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-(4-pyridin-3-ylpyrazol-1-yl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]pyrazol-1-yl]acetamide.
| Compound Name | 2-[2,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-(4-pyridin-3-ylpyrazol-1-yl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]pyrazol-1-yl]acetamide |
|---|---|
| PubChem CID | 159651534 |
| Molecular Formula | C143H110F15N49O7 |
| Molecular Weight | 2911.76 g/mol |
| Exact Mass | 2909.95 |
| IUPAC Name | 2-[2,5-dimethyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[5-methyl-4-[2-(trifluoromethyl)-4-pyridinyl]imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-(4-pyridin-3-ylpyrazol-1-yl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[2-(trifluoromethyl)-4-pyridinyl]pyrazol-1-yl]acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]pyrazol-1-yl]acetamide |
| SMILES | Cc1c(-c2ccnc(C(F)(F)F)c2)ncn1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1cc(-c2cn(CC(=O)Nc3ccc(-c4cnccn4)cn3)cn2)ccn1.Cc1nc(-c2ccnc(C(F)(F)F)c2)c(C)n1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(-c2ccnc(C(F)(F)F)c2)cn1CC(=O)Nc1ccc(-c2cnccn2)cn1.O=C(Cn1cc(-c2ccc(C(F)(F)F)nc2)cn1)Nc1ccc(-c2cnccn2)cn1.O=C(Cn1cc(-c2cccnc2)cn1)Nc1ccc(-c2cnccn2)cn1.O=C(Cn1cc(-c2ccnc(C(F)(F)F)c2)cn1)Nc1ccc(-c2cnccn2)cn1 |
| InChI | InChI=1S/C22H18F3N7O.2C21H16F3N7O.2C20H14F3N7O.C20H17N7O.C19H15N7O/c1-13-21(15-5-6-28-18(9-15)22(23,24)25)30-14(2)32(13)12-20(33)31-19-4-3-16(10-29-19)17-11-26-7-8-27-17;1-13-29-17(14-4-5-27-18(8-14)21(22,23)24)11-31(13)12-20(32)30-19-3-2-15(9-28-19)16-10-25-6-7-26-16;1-13-20(14-4-5-27-17(8-14)21(22,23)24)29-12-31(13)11-19(32)30-18-3-2-15(9-28-18)16-10-25-6-7-26-16;21-20(22,23)17-3-1-13(7-26-17)15-9-28-30(11-15)12-19(31)29-18-4-2-14(8-27-18)16-10-24-5-6-25-16;21-20(22,23)17-7-13(3-4-26-17)15-9-28-30(11-15)12-19(31)29-18-2-1-14(8-27-18)16-10-24-5-6-25-16;1-14-8-15(4-5-22-14)18-11-27(13-25-18)12-20(28)26-19-3-2-16(9-24-19)17-10-21-6-7-23-17;27-19(13-26-12-16(10-24-26)14-2-1-5-20-8-14)25-18-4-3-15(9-23-18)17-11-21-6-7-22-17/h3-11H,12H2,1-2H3,(H,29,31,33);2-11H,12H2,1H3,(H,28,30,32);2-10,12H,11H2,1H3,(H,28,30,32);2*1-11H,12H2,(H,27,29,31);2-11,13H,12H2,1H3,(H,24,26,28);1-12H,13H2,(H,23,25,27) |
| InChIKey | MRQASYIAVSRAQF-UHFFFAOYSA-N |
| XLogP | 23.69 |
| TPSA | 689.36 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 49 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 214 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2911.76 |
| LogP ≤ 5 | 23.69 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 49 |